Key Takeaways
- Biotalys’ BioFun-6 demonstrated strong efficacy against Botrytis and powdery mildew in field trials.
- Lower dose rates were effective, requiring only two-thirds of EVOCA’s dose in grapes and half in cucumbers.
- Independent trials in Europe and the U.S. confirmed BioFun-6’s potential as an alternative to existing biological and synthetic fungicides.
- The biofungicide market is expanding, with projected 12% annual growth, reaching $17 billion by 2030.
- Biotalys plans to continue BioFun-6 field trials in 2025 to further assess producibility and scalability.
Field Trials Confirm BioFun-6’s Effectiveness
Biotalys (Profile), an AgTech company specializing in protein-based biocontrol solutions, has announced positive results from initial field trials for its BioFun-6 program. Conducted in Europe and the U.S. by independent contract research organizations (CROs), the trials tested a lead AGROBODY™ candidate in:
- Grapes against Botrytis (grey mold)
- Cucumbers and tomatoes against powdery mildew
Lower Doses, Same Protection
The trials demonstrated that BioFun-6 maintained or improved disease control at significantly lower dosage rates:
- In grapes, BioFun-6 achieved the same protection as chemical fungicides at two-thirds the dose of EVOCA.
- In cucumbers, BioFun-6 maintained the same powdery mildew suppression at half the dose of EVOCA, outperforming a standard biological fungicide.
- In tomatoes, initial results indicated similar efficacy to leading biological and chemical solutions.
Biotalys CEO Highlights BioFun-6’s Potential
Commitment to Sustainability and Innovation
Commenting on the results, Kevin Helash, CEO of Biotalys, stated: “We are very pleased with the outcome of these promising field trials, which further validate the potential of our AGROBODY technology platform to deliver highly effective protein-based crop protection solutions. The data support BioFun-6’s efficacy in controlling fungi at significantly reduced dosage rates— a key milestone toward our goal of offering cost-effective, sustainable products to growers across diverse crops and pathogens. I’m incredibly proud of what our team has achieved and grateful for their dedication, bringing us closer to monetizing our portfolio while creating value for our growers, partners, and shareholders.”
Biotalys’ AGROBODY™ technology aims to provide protein-based alternatives to conventional fungicides, reducing the environmental impact of crop protection while maintaining high performance and cost-efficiency.
Next Steps For Biotalys
Further Testing in 2025 For BioFun-6
Biotalys plans to continue field trials throughout 2025, further testing BioFun-6 AGROBODY lead candidates to assess:
- Producibility and scalability for commercial application
- Effectiveness across different crops and pathogens
- Market positioning compared to synthetic and biological competitors
4 Comments